| dc.contributor.author | Karaçın, Cengiz | |
| dc.contributor.author | Öksüzoğlu, Berna | |
| dc.contributor.author | Demirci, Ayşe | |
| dc.contributor.author | Keskinkılıç, Merve | |
| dc.contributor.author | Baytemur, Naziyet Köse | |
| dc.contributor.author | Yılmaz, Funda | |
| dc.contributor.author | Selvi, Oğuzhan | |
| dc.contributor.author | Karaboyun, Kubilay | |
| dc.date.accessioned | 2023-05-06T17:23:34Z | |
| dc.date.available | 2023-05-06T17:23:34Z | |
| dc.date.issued | 2023 | |
| dc.identifier.issn | 1471-2407 | |
| dc.identifier.uri | https://doi.org/10.1186/s12885-023-10662-3 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11776/12160 | |
| dc.description.abstract | [Abstract Not Available] | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Bmc | en_US |
| dc.identifier.doi | 10.1186/s12885-023-10662-3 | |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023) [correction] | en_US |
| dc.type | correction | en_US |
| dc.relation.ispartof | Bmc Cancer | en_US |
| dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı | en_US |
| dc.authorid | Erul, Enes/0000-0002-2487-2087 | |
| dc.identifier.volume | 23 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.institutionauthor | Karaboyun, Kubilay | |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.authorwosid | Gumus, Mahmut/HTO-4176-2023 | |
| dc.authorwosid | Erul, Enes/AGJ-5340-2022 | |
| dc.identifier.wos | WOS:000941147400001 | en_US |
| dc.identifier.scopus | 2-s2.0-85148970683 | en_US |
| dc.identifier.pmid | 36849943 | en_US |
